Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

7066213

Reference Type

Journal Article

Title

Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE)

Author(s)

Peerally, MF; Bhandari, P; Ragunath, K; Barr, H; Stokes, C; Haidry, R; Lovat, L; Smart, H; Harrison, R; Smith, K; Morris, T; de Caestecker, JS; ,

Year

2019

Is Peer Reviewed?

Yes

Journal

Gastrointestinal Endoscopy
ISSN: 0016-5107

Publisher

MOSBY-ELSEVIER

Location

NEW YORK

Page Numbers

680-689

Language

English

PMID

30076843

DOI

10.1016/j.gie.2018.07.031

Web of Science Id

WOS:000461784300003

Abstract

Endoscopic resection (ER) is safe and effective for Barrett's esophagus (BE) containing high-grade dysplasia (HGD) or mucosal adenocarcinoma (T1A). The risk of metachronous neoplasia is reduced by ablation of residual BE by using radiofrequency ablation (RFA) or argon plasma coagulation (APC). These have not been compared directly. We aimed to recruit up to 100 patients with BE and HGD or T1A confirmed by ER over 1 year in 6 centers in a randomized pilot study.